Inpoza

Sobre este medicamento

Originator: Lynparza by AstraZeneca. · Manufacturer: Genvio Pharma. Indication & Dosage: Inpoza (Olaparib), generic Lynparza is a prescription medicine used to treat ovarian cancer, HER2- negative breast cancer. Olaparib is used to help maintain patients body's response to prior chemotherapy for ovarian cancer, fallopian tube cancer, or peritoneal cancer when the cancer has come back. Inpoza manufactured by Genvio Pharma Ltd. in Bangladesh. Olaparib has to take orally 400mg twice daily with or without food until the disease progresses or unacceptable toxicity. [50mg ~ (8 + 8= 16) capsules daily]. Olaparib has to take orally 300mg twice daily with or without food until the disease progresses or unacceptable toxicity. ** Do not substitute Olaparib tablets with capsules on a milligram-to-milligram basis due to differences in the dosing and bioavailability of each formulation. Side Effects: The most common adverse reactions of Olaparib are: Nausea , vomiting , loss of appetite , diarrhea , headache , bad taste in your mouth, dizziness, or tiredness. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.